Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
High blood pressure
Pharma
AZ nets key hypertension nod for Baxfendy, plus new Fasenra use
The FDA has given the all-clear to AZ’s baxdrostat—now christened Baxfendy—with a first-in-class approval to treat patients with high blood pressure.
Fraiser Kansteiner
May 18, 2026 11:23am
Granules recalls blood pressure med for failing to meet specs
Jul 9, 2025 8:46am
George Medicines' triple-combo blood pressure med wins FDA nod
Jun 9, 2025 11:13am
Lupin recalls 600K bottles of blood pressure med
Nov 25, 2024 1:20pm
George Medicines' combo hypertension prospect posts strong data
Aug 31, 2024 4:00am
Endo's patent claims against Eagle don't hold up, again
Aug 19, 2022 11:20am
